XtremeSorb Spill control products
Get XtremeSorb spill materials here!

Free Sites FAQ's Regulations Glossary Software Suppliers
Books Forum Poll Fun stuff Quiz Store
MSDS and safety supplies Search ALL our MSDS info
ILPI's Interactive Library of OSHA MSDS Regulations and Interpretations
previous topic OSHA Index next topic

Guidance for Hazard Classifications Re: Carcinogenicity (Non-Mandatory)

Appendix F to the Hazard Communication Standard, 29 CFR 1910.1200

[Note: Annotations made in green text below are tips/commentary by ILPI, not OSHA.]

The mandatory criteria for classification of a chemical for carcinogenicity under HCS (§ 1910.1200) are found in Appendix A.6 to this section. This non-mandatory Appendix provides additional guidance on hazard classification for carcinogenicity. Part A of Appendix F includes background guidance provided by GHS based on the Preamble of the International Agency for Research on Cancer (IARC) "Monographs on the Evaluation of Carcinogenic Risks to Humans" (2006). Part B provides IARC classification information. Part C provides background guidance from the National Toxicology Program (NTP) "Report on Carcinogens" (RoC), and Part D is a table that compares GHS carcinogen hazard categories to carcinogen classifications under IARC and NTP, allowing classifiers to be able to use information from IARC and NTP RoC carcinogen classifications to complete their classifications under the GHS, and thus the HCS.

Part A: Background Guidance1
Part B: International Agency for Research on Cancer (IARC)
Part C: National Toxicology Program (NTP), "Report on Carcinogens", Background Guidance
Part D: Table Relating Approximate Equivalences Among IARC, NTP RoC, and GHS Carcinogenicity Classifications

1 The text of Appendix F, Part A, on the IARC Monographs, is paraphrased from the 2006 Preamble to the "Monographs on the Evaluation of Carcinogenic Risks to Humans"; the Classifier is referred to the full IARC Preamble for the complete text. The text is not part of the agreed GHS text on the harmonized system developed by the OECD Task Force-HCL.

2 While most international agencies do not consider kidney tumors coincident with α2u-globulin nephropathy to be a predictor of risk in humans, this view is not universally held. (See: Doi et al., 2007).

3 Preamble of the International Agency for Research on Cancer (IARC) "Monographs on the Evaluation of Carcinogenic Risks to Humans" (2006).

4 See: http://ntp.niehs.nih.gov/go/15209

5 This evidence can include traditional cancer epidemiology studies, data from clinical studies, and/or data derived from the study of tissues or cells from humans exposed to the substance in question that can be useful for evaluating whether a relevant cancer mechanism is operating in people.

[77 FR 17885, March 26, 2012; 78 FR 9313, Feb. 8, 2013]

Entry last updated: Saturday, June 11, 2016. This hypermarked and content-enhanced page is copyright 2001-2017 by ILPI, all rights reserved. Unauthorized duplication or posting on other web sites is expressly prohibited. For questions, comments and concerns, please contact us at our MSDS email address.

The official, public domain, OSHA version of this document is available at https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=301.